OncoSec Medical, Inc. (ONCSQ)
0.0000
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
OncoSec Medical Net Income (Quarterly)
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2023 | -6.861M |
| October 31, 2022 | -8.061M |
| July 31, 2022 | -8.216M |
| April 30, 2022 | -6.247M |
| January 31, 2022 | -9.907M |
| October 31, 2021 | -9.809M |
| July 31, 2021 | -11.80M |
| April 30, 2021 | -9.442M |
| January 31, 2021 | -10.70M |
| October 31, 2020 | -13.23M |
| July 31, 2020 | -8.971M |
| April 30, 2020 | -9.888M |
| January 31, 2020 | -13.63M |
| October 31, 2019 | -9.760M |
| July 31, 2019 | -7.502M |
| April 30, 2019 | -6.883M |
| January 31, 2019 | -8.315M |
| October 31, 2018 | -7.576M |
| July 31, 2018 | -12.44M |
| April 30, 2018 | -10.06M |
| January 31, 2018 | -10.74M |
| October 31, 2017 | -5.900M |
| July 31, 2017 | -5.898M |
| April 30, 2017 | -4.561M |
| January 31, 2017 | -5.387M |
| Date | Value |
|---|---|
| October 31, 2016 | -5.604M |
| July 31, 2016 | -6.562M |
| April 30, 2016 | -6.251M |
| January 31, 2016 | -7.038M |
| October 31, 2015 | -7.037M |
| July 31, 2015 | -6.576M |
| April 30, 2015 | -5.987M |
| January 31, 2015 | -4.618M |
| October 31, 2014 | -4.061M |
| July 31, 2014 | -3.543M |
| April 30, 2014 | -3.817M |
| January 31, 2014 | -2.600M |
| October 31, 2013 | -2.052M |
| July 31, 2013 | -1.773M |
| April 30, 2013 | -1.729M |
| January 31, 2013 | -1.622M |
| October 31, 2012 | -2.027M |
| July 31, 2012 | -1.594M |
| April 30, 2012 | -0.8116M |
| January 31, 2012 | -2.672M |
| October 31, 2011 | 2.712M |
| July 31, 2011 | -3.253M |
| April 30, 2011 | -0.4994M |
| January 31, 2011 | -0.0043M |
| October 31, 2010 | -0.0024M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Anika Therapeutics, Inc. | 3.309M |
| Savara, Inc. | -40.23M |
| Vericel Corp. | 2.206M |